1. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000 6;18(6):679-685. PMID:
10872551.
2. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J. 2005 9;46(5):801-809. PMID:
16272771.
3. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001 1;163(1):19-25. PMID:
11208620.
4. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive day-time sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997 5;82(5):1313-1316. PMID:
9141509.
5. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999 12;282(22):2131-2135. PMID:
10591334.
6. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003 10;290(14):1906-1914. PMID:
14532320.
7. Natali A, L'Abbate A, Ferrannini E. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J. 2003 4;24(7):639-648. PMID:
12657222.
8. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005 8;3(8):1618-1627. PMID:
16102027.
9. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003 3;107(8):1129-1134. PMID:
12615790.
10. Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am J Epidemiol. 2003 11;158(9):844-851. PMID:
14585762.
11. Timmer JR, Ottervanger JP, Hoorntje JC, De Boer MJ, Suryapranata H, van't Hof AW, et al. Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia. J Intern Med. 2005 5;257(5):423-429. PMID:
15836658.
12. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke. 2002 7;33(7):1782-1785. PMID:
12105352.
13. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 3;365(9464):1046-1053. PMID:
15781100.
14. Dziewas R, Humpert M, Hopmann B, Kloska SP, Ludemann P, Ritter M, et al. Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol. 2005 11;252(11):1394-1398. PMID:
16021359.
15. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke. 1996 2;27(2):252-259. PMID:
8571419.
16. Hermann DM, Bassetti CL. Sleep-disordered breathing and stroke. Curr Opin Neurol. 2003 2;16(1):87-90. PMID:
12544862.
17. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke. 1992 12;23(12):1752-1760. PMID:
1448826.
18. Wessendorf TE, Teschler H, Wang YM, Konietzko N, Thilmann AF. Sleep-disordered breathing among patients with first-ever stroke. J Neurol. 2000 1;247(1):41-47. PMID:
10701896.
19. Schulz R, Seeger W, Fegbeutel C, Husken H, Bodeker RH, Tillmanns H, et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J. 2005 1;25(1):69-74. PMID:
15640325.
20. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 7 04; 102(1):42-47. PMID:
10880413.
21. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997 2;349(9050):462-466. PMID:
9040576.
22. Carlson LA, Bottiger LE, Ahfeldt PE. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta medica Scandinavica. 1979;206(5):351-360. PMID:
525434.
23. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 5;279(18):1477-1482. PMID:
9600484.
24. Godsland IF, Bruce R, Jeffs JA, Leyva F, Walton C, Stevenson JC. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Int J Cardiol. 2004 12;97(3):543-550. PMID:
15561346.
25. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000 4;283(14):1829-1836. PMID:
10770144.
26. Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP. Hematocrit levels in sleep apnea. Chest. 1994 9;106(3):787-791. PMID:
8082360.